These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 34505396)

  • 41. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.
    Forbes C; Shirran L; Bagnall AM; Duffy S; ter Riet G
    Health Technol Assess; 2001; 5(28):1-110. PubMed ID: 11701100
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phase III randomized trial of docetaxel-carboplatin versus paclitaxel-carboplatin as first-line chemotherapy for ovarian carcinoma.
    Vasey PA; Jayson GC; Gordon A; Gabra H; Coleman R; Atkinson R; Parkin D; Paul J; Hay A; Kaye SB;
    J Natl Cancer Inst; 2004 Nov; 96(22):1682-91. PubMed ID: 15547181
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Paclitaxel with carboplatin versus paclitaxel with carboplatin alternating with cisplatin as first-line chemotherapy in advanced epithelial ovarian cancer: preliminary results of a Hellenic Cooperative Oncology Group study.
    Skarlos DV; Aravantinos G; Kosmidis P; Athanassiadis A; Stathopoulos GP; Pavlidis N; Bafaloukos D; Karphathios S; Papakostas P; Bamia C; Fountzilas G
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-57-S15-61. PubMed ID: 9346224
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Carboplatin plus paclitaxel in the treatment of gynecologic malignancies: the Cleveland Clinic experience.
    Markman M; Kennedy A; Webster K; Kulp B; Peterson G; Belinson J
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-26-S15-29. PubMed ID: 9346218
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Tolerance induction in anaphylaxis to carboplatin].
    Herzinger T; Behr J; Przybilla B
    Dtsch Med Wochenschr; 2003 Jul; 128(30):1595-6. PubMed ID: 12884147
    [No Abstract]   [Full Text] [Related]  

  • 46. [Safety evaluation of adjuvant chemotherapy by weekly paclitaxel combined with weekly carboplatin in patients with postoperative non-small cell lung cancer].
    Hirose T; Nagao T; Kajikawa A; Sumi T; Sugimoto T; Hirose Y; Yoshida M; Kenzaki K
    Gan To Kagaku Ryoho; 2007 Sep; 34(9):1397-400. PubMed ID: 17876136
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Infusion reaction and anaphylaxis].
    Yoshida K; Shiono M; Ishioka C
    Gan To Kagaku Ryoho; 2011 Nov; 38(11):1753-7. PubMed ID: 22083179
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Non-steroidal anti-inflammatory drugs induce severe hematologic toxicities in lung cancer patients receiving pemetrexed plus carboplatin: A retrospective cohort study.
    Kawazoe H; Yano A; Ishida Y; Takechi K; Katayama H; Ito R; Yakushijin Y; Moriguchi T; Tanaka M; Tanaka A; Araki H
    PLoS One; 2017; 12(2):e0171066. PubMed ID: 28158216
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of the incidence of carboplatin hypersensitivity reactions in cancer patients.
    Navo M; Kunthur A; Badell ML; Coffer LW; Markman M; Brown J; Smith JA
    Gynecol Oncol; 2006 Nov; 103(2):608-13. PubMed ID: 16797060
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Incidence of infusion reactions induced by cetuximab chemotherapy].
    Maeda T; Tatematsu M; Muro K
    Gan To Kagaku Ryoho; 2011 Jun; 38(6):963-6. PubMed ID: 21677487
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of proton pump inhibitors on severe haematotoxicity induced after first course of pemetrexed/carboplatin combination chemotherapy.
    Araki R; Keira T; Masuda Y; Tanaka T; Yamada H; Hamamoto T
    J Clin Pharm Ther; 2019 Apr; 44(2):276-284. PubMed ID: 30552862
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anaphylaxis to carboplatin following multiple previous uncomplicated courses.
    Sood AK; Gelder MS; Huang SW; Morgan LS
    Gynecol Oncol; 1995 Apr; 57(1):131-2. PubMed ID: 7705695
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Safety and Efficacy of Cisplatin Treatment after Carboplatin Hypersensitivity Reactions in Gynecologic Malignancies].
    Matsuoka N; Yokoyama T; Fujimoto E; Sakai M; Okame S; Shiroyama Y; Yokoyama T; Takehara K
    Gan To Kagaku Ryoho; 2017 Dec; 44(13):2091-2095. PubMed ID: 29361624
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Paclitaxel plus carboplatin in the treatment of patients with advanced lung cancer: a Vanderbilt University Cancer Center phase II trial (LUN-46).
    Johnson DH; Paul DM; Hande KR; DeVore R
    Semin Oncol; 1996 Dec; 23(6 Suppl 16):42-6. PubMed ID: 9007120
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hypersensitivity reactions associated with platinum-containing antineoplastic agents for thoracic malignancies.
    Tamiya M; Kuhara H; Hirashima T; Kondo Y; Santo M; Morishita N; Suzuki H; Sasada S; Okamoto N; Kobayashi M; Kawase I
    Anticancer Res; 2011 Dec; 31(12):4525-8. PubMed ID: 22199326
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epidemiology of drug-induced anaphylaxis in a tertiary hospital in Korea.
    Park HK; Kang MG; Yang MS; Jung JW; Cho SH; Kang HR
    Allergol Int; 2017 Oct; 66(4):557-562. PubMed ID: 28291680
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Stopping paclitaxel premedication after two doses in patients not experiencing a previous infusion hypersensitivity reaction.
    Berger MJ; Vargo C; Vincent M; Shaver K; Phillips G; Layman R; Macrae E; Mrozek E; Ramaswamy B; Wesolowski R; Shapiro CL; Lustberg MB
    Support Care Cancer; 2015 Jul; 23(7):2019-24. PubMed ID: 25519756
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Exploratory phase III study of paclitaxel and cisplatin versus paclitaxel and carboplatin in advanced ovarian cancer.
    Neijt JP; Engelholm SA; Tuxen MK; Sorensen PG; Hansen M; Sessa C; de Swart CA; Hirsch FR; Lund B; van Houwelingen HC
    J Clin Oncol; 2000 Sep; 18(17):3084-92. PubMed ID: 10963636
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Adenosine triphosphate-based chemotherapy response assay predicts long-term survival of primary epithelial ovarian cancer.
    Li LY; Kim SW; Nam EJ; Lee J; Kim S; Kim YT
    Int J Gynecol Cancer; 2019 Feb; 29(2):334-340. PubMed ID: 30718314
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Incidence of Anaphylaxis to Sugammadex in a Single-Center Cohort of 19,821 Patients.
    Burbridge MA
    Anesth Analg; 2021 Jan; 132(1):93-97. PubMed ID: 32243295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.